Long-term benefits of induction therapy in NMO: a case report.
Department of Public Health, Clinical and Molecular Medicine, Multiple Sclerosis Center, University of Cagliari, Via Is Guadazzonis n. 2, 09126, Cagliari, Italy, jessicafrau@hotmail.it.
Jessica
J
Frau
Giancarlo
G
Coghe
Lorena
L
Lorefice
Giuseppe
G
Fenu
Eleonora
E
Cocco
D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D060828:Induction Chemotherapy / Q000379:methods*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000175:diagnosis; D009471:Neuromyelitis Optica / Q000175:diagnosis / Q000188:drug therapy*; D043025:Oligoclonal Bands / Q000134:cerebrospinal fluid; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D043025:Oligoclonal Bands; D000069283:Rituximab; D008942:Mitoxantrone